CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy

Platinum-based chemotherapy is the first-line treatment for small cell lung cancer (SCLC). However, due to patients developing a resistance to the drug, most experience relapse and their cancer can become untreatable. A large number of recent studies have found that platinum drug sensitivity of vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Yonglin, Qiu, Zhengang, Yao, Zifu, Lin, Anqi, Qin, Yimin, Sha, Ruizhan, Wei, Ting, Wang, Yanru, Cheng, Quan, Zhang, Jian, Luo, Peng, Shen, Weitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787262/
https://www.ncbi.nlm.nih.gov/pubmed/35087829
http://dx.doi.org/10.3389/fcell.2021.770811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787262/
https://www.ncbi.nlm.nih.gov/pubmed/35087829
http://dx.doi.org/10.3389/fcell.2021.770811

Ejemplares similares